Stock CANNABIS SCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Cannabis Science, Inc.

Equities

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
GBX International Group Inc. agreed to Spin-Off Cannabis Science, Inc.
CI
Cannabis Science Inc. Successfully Launches its $CSI Cannabis Science Coin for its CSi-EDP Utility Project Valuation Tracking
CI
Thermic Sciences International signed a share exchange agreement to acquire Cannabis Science, Inc.
CI
Canopy Growth : BC Centre on Substance Use hosts inaugural Cannabis Science Symposium
AQ
NHS Industries, Ltd. and Cannabis Science, Inc. Agree to Terminate the Previously Announced Joint Venture Agreement
CI
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
GL
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
GL
Cannabis Science Partners With NHS Industries to Launch the CBIS CDN Economic Development Plan
CI
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
GL
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
GL
Cannabis Science Successfully Moves Operations to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CI
Cannabis Science, Inc. Successfully Completes Lab Testing for Its Proprietary, Short-Time Vacuum Distillation Process for Distribution of Purified High CBDA and CBD Water-Soluble Powders and Extracts Internationally
GL
Mr. Raymond C. Dabney Prepares Cannabis Science for the Next Level With Key Acquisitions Negotiated and Planned Mergers, a New Branding Splash, and a Black-Tie Dinner Awards Gala for the Ages
GL
Cannabis Science Propels Cancer Clinical Trials, Appoints Cellular Cancer Specialist Dr. Sulma Mohammed, Professor of Cancer Biology, Purdue University, to the Company’s Scientific Advisory Board
GL
Cannabis Science, Inc. Appoints Sulma Mohammed to its Scientific Advisory Board
CI
GHC Summit at Harvard Medical School Announces Cannabis Science as Industry Partner in the Launch of the International Phytomedicines Institute at Harvard Medical School
GL
Cannabis Science and Dana-Farber Cancer Institute Sign a New Research Agreement to Investigate Proprietary Extract From Justicia Plant
GL
Cannabis Science, Inc. and Dana-Farber Cancer Institute, Inc. Sign New Research Agreement to Investigate Proprietary Extract from Justicia Plant
CI
Cannabis Science Releases Clinical Drug-Development Pipeline as it Transitions Into Clinical Trials; Right on Time for the Upcoming Global Health Catalyst Summit at Harvard Medical School, May 24-26, 2019
GL
Cannabis Science Expands Into Canadian Market With Wholly-Owned Subsidiary Cannabis Science Canada Inc., Commences Negotiations for Canadian Land, Licenses, and Expansion Capital
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Cannabis Science, Inc.